Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET/MRI to Stage Prostate Cancer Patients
Sponsor: IRCCS San Raffaele
Summary
The main goal of this phase II clinical trial is to define a novel approach of staging prostate cancer (PCa) patients by using a fully integrated positron emission tomography/ magnetic resonance imaging (PET/MRI) system with 68Ga-prostate specifica membrane antigen (PSMA) and 68Ga-RM2 (bombesin antagonist). 50 patients with biopsy proven PCa will be studied by PET/MRI with 68Ga-PSMA and with 68Ga-RM2 and then will undergo prostatectomy and pelvic lymphadenectomy.
Official title: Phase II Monocentric Study to Evaluate a Novel Approach for Staging Prostate Cancer Patients by Using a Fully Integrated Hybrid PET/MRI
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2020-09-09
Completion Date
2025-09-30
Last Updated
2024-07-03
Healthy Volunteers
No
Conditions
Interventions
68Ga-PSMA
all patients will undergo PET/MRI with 68Ga-PSMA and 68Ga-RM2 prior to surgical intervention
68Ga-RM2
all patients will undergo PET/MRI with 68Ga-PSMA and 68Ga-RM2 prior to surgical intervention
Locations (1)
IRCCS Ospedale San Raffaele
Milan, Italy